Condensed Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total	Class 1 Common Stock	Class 2 Common Stock	Common Stock Class 1 Common Stock	Common Stock Class 2 Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2020				92,760,000	8,197,000
Beginning balance at Dec. 31, 2020	$ 3,810			$ 9	$ 1	$ 148,677	$ (144,877)	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Reverse recapitalization and PIPE financing (in shares)				44,522,000	(1,659,000)
Reverse recapitalization and PIPE financing	329,886			$ 5		329,881
Fair value of earnout shares	(230,995)					(230,995)
Issuance and vesting of earnout shares (in shares)				10,204,000	713,000
Issuance and vesting of earnout shares	237,009			$ 1		237,008
Issuance of common stock under stock plans (in shares)				3,875,000
Issuance of common stock under stock plans	5,271					5,271
Exchange of shares upon sale of Class 2 common stock ( in shares)				2,028,000	(2,028,000)
Shares issued for exercise of warrants (in shares)				2,000
Shares issued for exercise of warrants	26					26
Stock-based compensation expense	20,446					20,446
Foreign currency translation	0
Net loss	(44,724)						(44,724)
Ending balance (in shares) at Sep. 30, 2021				153,391,000	5,223,000
Ending balance at Sep. 30, 2021	320,729			$ 15	$ 1	510,314	(189,601)	0
Beginning balance (in shares) at Jun. 30, 2021				150,649,000	7,251,000
Beginning balance at Jun. 30, 2021	324,638			$ 15	$ 1	503,029	(178,407)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under stock plans (in shares)				714,000
Issuance of common stock under stock plans	1,371					1,371
Exchange of shares upon sale of Class 2 common stock ( in shares)				2,028,000	(2,028,000)
Stock-based compensation expense	5,914					5,914
Foreign currency translation	0
Net loss	(11,194)						(11,194)
Ending balance (in shares) at Sep. 30, 2021				153,391,000	5,223,000
Ending balance at Sep. 30, 2021	320,729			$ 15	$ 1	510,314	(189,601)	0
Beginning balance (in shares) at Dec. 31, 2021		159,413,000	3,396,000	159,413,000	3,396,000
Beginning balance at Dec. 31, 2021	309,634			$ 15	$ 1	516,987	(206,077)	(1,292)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under stock plans (in shares)				1,839,000
Issuance of common stock under stock plans	3,227			$ 1		3,226
Exchange of shares upon sale of Class 2 common stock ( in shares)				3,396,000	(3,396,000)
Exchange of shares upon sale of Class 2 common stock	0			$ 1	$ (1)
Stock-based compensation expense	20,293					20,293
Foreign currency translation	(15,927)							(15,927)
Net loss	(65,447)						(65,447)
Ending balance (in shares) at Sep. 30, 2022		164,648,000	0	164,648,000	0
Ending balance at Sep. 30, 2022	251,780			$ 17	$ 0	540,506	(271,524)	(17,219)
Beginning balance (in shares) at Jun. 30, 2022				160,536,000	3,396,000
Beginning balance at Jun. 30, 2022	272,806			$ 16	$ 1	532,409	(250,315)	(9,305)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under stock plans (in shares)				716,000
Issuance of common stock under stock plans	1,157					1,157
Exchange of shares upon sale of Class 2 common stock ( in shares)				3,396,000	(3,396,000)
Exchange of shares upon sale of Class 2 common stock	0			$ 1	$ (1)
Stock-based compensation expense	6,940					6,940
Foreign currency translation	(7,914)							(7,914)
Net loss	(21,209)						(21,209)
Ending balance (in shares) at Sep. 30, 2022		164,648,000	0	164,648,000	0
Ending balance at Sep. 30, 2022	$ 251,780			$ 17	$ 0	$ 540,506	$ (271,524)	$ (17,219)